JP2001506606A5 - - Google Patents

Download PDF

Info

Publication number
JP2001506606A5
JP2001506606A5 JP1998524829A JP52482998A JP2001506606A5 JP 2001506606 A5 JP2001506606 A5 JP 2001506606A5 JP 1998524829 A JP1998524829 A JP 1998524829A JP 52482998 A JP52482998 A JP 52482998A JP 2001506606 A5 JP2001506606 A5 JP 2001506606A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998524829A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001506606A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/021649 external-priority patent/WO1998023565A2/en
Publication of JP2001506606A publication Critical patent/JP2001506606A/ja
Publication of JP2001506606A5 publication Critical patent/JP2001506606A5/ja
Ceased legal-status Critical Current

Links

JP52482998A 1996-11-26 1997-11-26 プロテアーゼインヒビターとしてのアミノグアニジンおよびアルコキシグアニジン Ceased JP2001506606A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3182296P 1996-11-26 1996-11-26
US60/031,822 1996-11-26
PCT/US1997/021649 WO1998023565A2 (en) 1996-11-26 1997-11-26 Aminoguanidines and alkoxyguanidines as protease inhibitors

Publications (2)

Publication Number Publication Date
JP2001506606A JP2001506606A (ja) 2001-05-22
JP2001506606A5 true JP2001506606A5 (https=) 2005-08-11

Family

ID=21861593

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52482998A Ceased JP2001506606A (ja) 1996-11-26 1997-11-26 プロテアーゼインヒビターとしてのアミノグアニジンおよびアルコキシグアニジン

Country Status (24)

Country Link
US (5) US6235778B1 (https=)
EP (1) EP0944590B1 (https=)
JP (1) JP2001506606A (https=)
KR (1) KR100587546B1 (https=)
CN (1) CN1237961A (https=)
AR (1) AR008327A1 (https=)
AT (1) ATE214693T1 (https=)
AU (1) AU725058B2 (https=)
BR (1) BR9713328A (https=)
CA (1) CA2273023C (https=)
DE (1) DE69711222T2 (https=)
DK (1) DK0944590T3 (https=)
EA (1) EA002740B1 (https=)
ES (1) ES2174309T3 (https=)
HU (1) HUP0000733A3 (https=)
IL (1) IL130102A (https=)
IN (1) IN190530B (https=)
NO (1) NO314140B1 (https=)
NZ (1) NZ336093A (https=)
PL (1) PL333434A1 (https=)
PT (1) PT944590E (https=)
TW (1) TW499412B (https=)
WO (1) WO1998023565A2 (https=)
ZA (1) ZA9710646B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI222441B (en) 1997-11-26 2004-10-21 Dimensional Pharm Inc Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
US6344486B1 (en) 1998-04-03 2002-02-05 3-Dimensional Pharmaceuticals, Inc. Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
WO1999055355A1 (en) 1998-04-24 1999-11-04 3-Dimensional Pharmaceuticals, Inc. Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
JP4554077B2 (ja) 1998-06-11 2010-09-29 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ピラジノンプロテアーゼインヒビター
AU3731400A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
US6544541B1 (en) * 1999-06-02 2003-04-08 Cardiovascular Solutions, Inc. Devices and compounds for treating arterial restenosis
CA2415932A1 (en) 2000-07-17 2002-01-24 3-Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine pyrazinones as protease inhibitors
CA2417914A1 (en) 2000-08-04 2002-02-14 3-Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine protease inhibitors
KR100371008B1 (ko) * 2000-08-05 2003-02-06 조동련 혈소판 응집 억제제 부착 스텐트의 그 제조 방법
UA75093C2 (en) * 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
EP1419172A4 (en) * 2001-08-03 2007-10-03 Univ Leland Stanford Junior BIDIRECTIONAL SYNTHESIS OF OLIGOGUANIDINTRANSPORTING MEANS
US20060264608A1 (en) * 2001-08-03 2006-11-23 Wender Paul A Bi-directional synthesis of oligoguanidine transport agents
AU2003234382B2 (en) * 2002-05-13 2010-07-08 Becton, Dickinson And Company Protease inhibitor sample collection system
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
JP2008544987A (ja) * 2005-06-30 2008-12-11 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト 殺虫性の(二置換プロペニル)フェニルアルキル置換複素環式環を調製するための改善された方法
JP2009521472A (ja) * 2005-12-22 2009-06-04 シェーリング コーポレイション 心肺手術の合併症の予防としてのトロンビンレセプターアンタゴニスト
TWI618544B (zh) 2006-12-26 2018-03-21 藍瑟斯醫學影像公司 使心臟神經分布顯像之配位體
WO2010134345A1 (ja) * 2009-05-20 2010-11-25 積水メディカル株式会社 血液凝固時間延長剤
AU2011253052B2 (en) 2010-05-11 2015-05-14 Lantheus Medical Imaging, Inc. Compositions, methods and systems for the synthesis and use of imaging agents
CA2824599C (en) * 2010-12-31 2020-03-10 Astrazeneca Uk Limited Arginase inhibitors and methods of use thereof
JP2014515352A (ja) 2011-05-17 2014-06-30 ベリコ メディカル インコーポレイティッド シアリダーゼ阻害剤を用いた血小板の保存の改善法
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
CN102850451B (zh) * 2011-06-29 2014-05-07 辽宁诺康生物制药有限责任公司 具有抑制纤溶酶活性的重组textilinin-1及其制备方法和应用
CA3194125A1 (en) 2012-04-12 2013-10-17 The Trustees Of The University Of Pennsylvania Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
EP2903430A1 (en) 2012-10-05 2015-08-12 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
WO2014120886A1 (en) 2013-01-30 2014-08-07 Velico Medical, Inc. Platelet additive solution having a self-assembling hydrogel-forming peptide
US9555016B2 (en) 2013-06-10 2017-01-31 Covidien Lp Lytic agents for use in treating intravascular clots
CN107382869A (zh) * 2017-08-01 2017-11-24 李凯 一种治疗中风后遗症的化合物及制备方法和应用
GB2568550B (en) * 2017-11-21 2021-06-30 Univ Cape Town Method of synthesising 6-deoxy-6-amino-ß-d-glucopyranoside-containing polymers
WO2022016345A1 (zh) * 2020-07-20 2022-01-27 深圳迈瑞生物医疗电子股份有限公司 一种组合物的血小板解聚用途、解聚试剂及解聚方法
GB202108544D0 (en) * 2021-06-15 2021-07-28 Z Factor Ltd Compounds and their use for the treatment of alpha1-antitrypsin deficiency
CN115772196A (zh) * 2021-09-08 2023-03-10 赛诺哈勃药业(成都)有限公司 一种纤溶酶抑制活性的化合物、其制备方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131218A (en) * 1961-02-15 1964-04-28 Smith Kline French Lab N-amino guanidine derivatives
US3271448A (en) 1961-11-21 1966-09-06 Pfizer & Co C Phenoxyalkyl aminoguanidines
BE663481A (https=) * 1964-05-05
US3413303A (en) * 1965-09-27 1968-11-26 Ciba Geigy Corp Aralkenyloxyguanidines
JPS57178739A (en) 1981-04-27 1982-11-04 Mitsubishi Heavy Ind Ltd Bead supplying device for tire molding machine
US4429146A (en) * 1982-04-15 1984-01-31 Gaf Corporation Substituted diphenyl ether herbicides and process for use
JPS6229566A (ja) 1985-07-30 1987-02-07 Taiyo Yakuhin Kogyo Kk 新規グアニジノメチル安息香酸誘導体
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
EP0604022A1 (en) 1992-12-22 1994-06-29 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method for its manufacture
TW257757B (https=) 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
GB9318637D0 (en) 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
US6087479A (en) 1993-09-17 2000-07-11 Nitromed, Inc. Localized use of nitric oxide-adducts to prevent internal tissue damage
US5466811A (en) 1994-07-18 1995-11-14 Merck & Co., Inc. Dioxolenylmethyl carbamates pro moieties for amine drugs
US5643580A (en) 1994-10-17 1997-07-01 Surface Genesis, Inc. Biocompatible coating, medical device using the same and methods
ES2235174T3 (es) 1994-10-17 2005-07-01 Kabushikikaisha Igaki Iryo Sekkei Stent liberador de medicamento.
US5637113A (en) 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
DE19514104C2 (de) 1995-04-13 1997-05-28 Behringwerke Ag Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial
HU211262A9 (hu) 1995-05-12 1995-11-28 Hoechst Ag Benzoil-guanidinek
WO1997011693A1 (en) 1995-09-29 1997-04-03 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
US5792769A (en) 1995-09-29 1998-08-11 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
GB9525620D0 (en) 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds
WO1997024135A1 (en) 1995-12-29 1997-07-10 3-Dimensional Pharmaceuticals, Inc. Amidino protease inhibitors
US5891909A (en) 1996-03-29 1999-04-06 3-Dimensional Pharmaceuticals, Inc. Amidinohydrazones as protease inhibitors
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds

Similar Documents

Publication Publication Date Title
JP2000510921A5 (https=)
JP2000514473A5 (https=)
JP2000512783A5 (https=)
JP2001508625A5 (https=)
JP2000507473A5 (https=)
JP2000512094A5 (https=)
JP2001502493A5 (https=)
JP2001500249A5 (https=)
JP2001507726A5 (https=)
JP2000504881A5 (https=)
JP2000501324A5 (https=)
JP2001501759A5 (https=)
JP2001503087A5 (https=)
JP2001500475A5 (https=)
JP2001501851A5 (https=)
JP2001503623A5 (https=)
JP2001501924A5 (https=)
JP2000511574A5 (https=)
JP2000514077A5 (https=)
JP2000506091A5 (https=)
JP2001509835A5 (https=)
JP2000504138A5 (https=)
JP2001503017A5 (https=)
JP2001502735A5 (https=)
JP2001506606A5 (https=)